🟢 Neuroone Medical Technologies is trading 6.25% up today after orders climbed 43% and backlog hit record

Neuroone Medical Technologies is trading at $1.94 (+6.25%) after new orders climbed 43% and gross margin expanded to 59.9%.

• Fiscal third-quarter product revenue hit $1.97 million, up 16% year over year.
• Orders climbed 43% to $2.7 million, creating a record $1.7 million backlog; manufacturing constraints lowered fiscal 2026 recognized-revenue guidance to $9.2 million–$10.5 million.
• The stock is extending its 20.39% gain from August 13; trading volume was not provided.